EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--May 11, 2006--Esprit Pharma, Inc. today announced that it has appointed Glenn M. Esgro Vice President of Trade. Mr. Esgro was most recently Sr. Director of Trade for Biovail Pharmaceuticals, Inc. (BVF: NYSE). “We are most pleased to have Glenn join our management team at Esprit Pharma”, said Greg Stokes, President and Chief Operating Officer of Esprit. “With his extensive national account sales and sales management experience, Glenn brings the sort of expertise that will greatly help Esprit Pharma achieve its stated goal of pre-eminence in the Specialty Pharma arena”, concluded Mr. Stokes.